A qualitative exploration of the facilitators and barriers to early diagnosis and treatment of head and neck cancer: Perceptions of patients and carers. (30th September 2022)

• Record Type: Journal Article
• Authors: Venchiarutti, Rebecca L.; Pho, Lily; Clark, Jonathan R.; Palme, Carsten E.; Young, Jane M.
• Is Part Of: European journal of cancer care. Volume 31:Number 6(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-09-30
• Subjects: access to healthcare -- cancer -- health seeking -- lived experience -- qualitative -- remote/rural healthcare; Cancer -- Nursing -- Periodicals; 616.994
• DOI: 10.1111/ecc.13718
• Languages: English
• ISSNs: 0961-5423

Abstract

Abstract: Objective: The objective of this study to explore experiences of patients and carers of the pathway to diagnosis and treatment of head and neck cancer (HNC), focusing on differences based on remoteness of residence. Methods: Patients ≥6 months post‐treatment completion, and their carers, were recruited. Semi‐structured interviews, guided by the Model of Pathways to Treatment as the theoretical framework, were conducted to examine pathways to treatment of HNC and facilitators and barriers to early diagnosis and treatment. Thematic analysis with an iterative and data‐driven approach was used to identify themes. Results: A total of 39 patients and 17 carers participated in the interviews. Facilitators of timely diagnosis and treatment included a sense of urgency from health care professionals (HCPs), advocacy by the HCP or carers, and leveraging social capital. Distance to services, financial costs, and a perceived lack of emotional investment by HCPs arose as barriers to timely diagnosis and treatment. Participants were often able to rationalise that not all delays were negative, depending causes and expected impact on cancer management. Conclusion: The findings highlight the complex nature of factors facilitating and impeding early HNC diagnosis and treatment that may be targeted in interventions to support patients and meet important benchmarks for high‐quality cancer care.